South African eCTD Module 1

Schema version 3.0

sg-regional.xml md5: b4ca1bd1aa705dec0bba78b3292610bb

Envelope

Application

SAHPRA National Procedure

Application ID cacdbbciajaa1
Application Number 987651
987652
987653
Proprietary Name afriCapsule Forte 400mg/100mg
afriCapsule 200mg/50mg
afriCapsule HD 100mg/25mg
Dosage Form Capsule
INN ibuprofen
codeine
APIMF Number 0001-D
0002-D
PMF Number PMF0041/2021
PMF0023/2019
VAMF Number VAMF0056/2020
VAMF0106/2021
SMF Number V071
L102
S083

Submission

Clone

Evaluation Path Priority
Submission Lead Pharmacovigilance
Submission Number 24123451
24123452
24123453

Submission

Type IA-Quality

Evaluation Path Priority
Submission Lead Pharmacovigilance
Submission Number 24123454
24123455
24123456

Sequence

#

Sequence Type Response-Clinical
Response-Inspectorate
Sequence Description Change of Address of Applicant
Sequence Date 2024-03-06
Sequence Number 0012
Related Sequence Number 0010

Multiple Applications

#

Application Number / Proprietary Name 987654.1 / ABC
Application Number / Proprietary Name 987655.2 / LMN
Application Number / Proprietary Name 987656.3 / XYZ

Contact

Local Applicant

Contact Name Dr. Portia Chabalala
Contact Email portia.chabalala@pharma-inc.co.za

Contact

Technical

Contact Name Johan Van Der Merwe
Contact Email johan.vdmerwwe@pharma-inc.co.za

Module 1 South Africa

1.0

Correspondence

1.0.1
Letter of Application
  • [SEQUENCE] Letter of Application [DESCRIPTION] (new)
  • 1.0.2
    Note to Evaluator
  • [SEQUENCE] Note to Evaluator (new)
  • 1.0.3
    Correspondence from SAHPRA
  • Correspondence [DATE] [DESCRIPTION] (new)
  • 1.0.4
    Response to SAHPRA Request
  • Response [DATE OF CORRESPONDENCE FROM SAHPRA] [DESCRIPTION] (new)
  • 1.0.5
    Meeting Information
  • Meeting Information [DESCRIPTION] (new)
  • 1.2

    Application

    1.2.1
    Application Form
  • [SEQUENCE] App Form [PRODUCT] [STRENGTH] [DESCRIPTION] PDF (new)
  • [SEQUENCE] App Form [PRODUCT] [STRENGTH] [DESCRIPTION] Word (new)
  • 1.2.2

    Annexes

    1.2.2.1
    Proof of Payment
  • [SEQUENCE] Proof of Payment [DESCRIPTION] (new)
  • 1.2.2.2
    Letter of Authorisation
  • Letter of Authorisation [DESCRIPTION] (new)
  • 1.2.2.3
    Dossier Product Batch Information
  • Dossier Product Batch Information [DESCRIPTION] (new)
  • 1.2.2.4
    Electronic Copy Declaration
  • [SEQUENCE] Electronic Copy Declaration [DESCRIPTION] (new)
  • 1.2.2.5
    Curriculum Vitae of the Person Responsible for Pharmacovigilance
  • Curriculum Vitae of the Person Responsible for Pharmacovigilance [DESCRIPTION] (new)
  • 1.2.2.6
    API Change Control
  • API Change Control [DESCRIPTION] (new)
  • 1.2.2.7
    EMA Certificate for a Vaccine Antigen Master File (VAMF)
  • EMA Certificate for a Vaccine Antigen Master File (VAMF) [DESCRIPTION] (new)
  • 1.2.2.8
    EMA Certificate for a Plasma Master File (PMF)
  • EMA Certificate for a Plasma Master File (PMF) [DESCRIPTION] (new)
  • 1.2.2.9
    Declaration of Sameness for Replicas and Clones
  • Declaration of Sameness for Replicas and Clones [DESCRIPTION] (new)
  • 1.2.2.10
    Letter of Permission from HCR for Replica
  • Letter of Permission from HCR for Replica [REPLICANAME] (new)
  • 1.2.2.A
    Additional Annexes
  • Additional Annexes [DESCRIPTION] (new)
  • 1.2.3

    Change in Applicant

    1.2.3.1
    Letter of Authorisation from Product Owner to New Registrant
  • Letter of Authorisation from Product Owner to New Registrant [APPLICANT] (new)
  • 1.2.3.2
    Written Confirmation of Hand-over of Dossier
  • Written Confirmation of Hand-over of Dossier [APPLICANT] (new)
  • 1.2.4
    Patent Declaration
  • Patent Declaration (new)
  • 1.2.5
    Checklists, Validation Templates
  • [SEQUENCE] Validation Templates PDF (new)
  • [SEQUENCE] Validation Templates Word (new)
  • 1.2.A
    Additional Administrative Information
  • Additional Admin Info [DESCRIPTION] (new)
  • 1.3

    South African Product Information

    1.3.1

    South African Professional Information

    1.3.1.1

    Professional Information (PI)

    1.3.1.1.1
    PI - Approved
  • PI – Approved [DATE] PDF (new)
  • PI – Approved [DATE] Word (new)
  • 1.3.1.1.2
    PI - Clean
  • PI - Clean PDF (new)
  • PI - Clean Word (new)
  • 1.3.1.1.3
    PI - Annotated
  • PI - Annotated PDF (new)
  • PI - Annotated Word (new)
  • 1.3.1.2

    Standard References

    1.3.1.2.1
    Reference Product - Local
  • Reference Product – Local [PRODUCTNAME] (new)
  • 1.3.1.2.2
    Other References
  • Other References (new)
  • 1.3.2

    Patient Information Leaflet (PIL)

    1.3.2.1
    PIL - Approved
  • PIL - Approved [DATE] PDF (new)
  • PIL - Approved [DATE] Word (new)
  • 1.3.2.2
    PIL - Clean
  • PIL - Clean PDF (new)
  • PIL - Clean Word (new)
  • 1.3.2.3
    PIL - Annotated
  • PIL - Annotated PDF (new)
  • PIL - Annotated Word (new)
  • 1.3.3

    Labels

    1.3.3.1
    Labels - Approved
  • Labels - Approved [DATE] PDF (new)
  • Labels - Approved [DATE] Word (new)
  • 1.3.3.2
    Labels - Clean
  • Labels - Clean PDF (new)
  • Labels - Clean Word (new)
  • 1.3.3.3
    Labels - Annotated
  • Labels - Annotated PDF (new)
  • Labels - Annotated Word (new)
  • 1.3.4
    Braille
  • Braille (new)
  • 1.3.5
    Foreign Prescribing and Patient Information
  • Foreign Prescribing and Patient Information (new)
  • 1.3.6

    Artwork and Samples

    1.3.6.1
    Statement Confirming Submission of Samples
  • Statement Confirming Submission of Samples (new)
  • 1.3.6.2
    Artwork and Pictures of Samples
  • Artwork and Pictures of Samples (new)
  • 1.3.6.3
    Batch Manufacturing Record of the Sample
  • Batch Manufacturing Record of the Sample (new)
  • 1.3.6.4
    CoA of the Sample
  • CoA of the Sample (new)
  • 1.4

    Information about the Experts

    1.4.1
    Quality
  • Quality (new)
  • 1.4.2
    Nonclinical
  • Nonclinical (new)
  • 1.4.3
    Clinical
  • Clinical (new)
  • 1.5

    Specific Requirements for different Types of Applications

    1.5.1
    Literature Based Submissions
  • Literature Based Submissions (new)
  • 1.5.2

    Amendments/Variations

    1.5.2.1
    Tabulated Schedule of Amendments
  • Tabulated Schedule of Amendments (new)
  • 1.5.2.2

    Medicines Register Details

    1.5.2.2.1
    Medicines Register Details
  • Medicines Register Details (new)
  • 1.5.2.2.2
    Registration Certificates
  • Registration Certificates (new)
  • 1.5.2.3

    Affidavit by Responsible Pharmacist

  • Affidavit by Responsible Pharmacist (new)
  • 1.5.3
    Proprietary Name Applications and Changes
  • Proprietary Name Applications and Changes (new)
  • 1.5.4
    Genetically Modified Organisms
  • Genetically Modified Organisms (new)
  • 1.5.6

    Generic Applications (BTIF)

    1.5.6.1
    Generic Applications (BTIF)
  • Generic Applications (BTIF) PDF (new)
  • Generic Applications (BTIF) Word (new)
  • 1.5.6.2
    Biowaiver
  • Biowaiver PDF (new)
  • Biowaiver Word (new)
  • 1.5.7
    Abridged Applications (Abridged/Verified Review Document)
  • Abridged Applications (Abridged/Verified Review Document) PDF (new)
  • Abridged Applications (Abridged/Verified Review Document) Word (new)
  • 1.5.A
    Additional Types of Applications Specific Requirements
  • Additional Types Applications [TYPEOFAPPLICATION] [DESCRIPTION] (new)
  • 1.6

    Environmental Risk Assessment

    1.6.1
    Non-GMO (Genetically Modified Organisms)
  • Non-GMO (Genetically Modified Organisms) (new)
  • 1.6.2
    GMO (Genetically Modified Organisms)
  • GMO (Genetically Modified Organisms) (new)
  • 1.7

    Good Manufacturing Practice

    1.7.1
    Date of Last Inspection of each Site
  • Date of Last Inspection of each Site (new)
  • 1.7.2
    Inspection Reports or Equivalent Document
  • Inspection Reports or Equivalent Document (new)
  • 1.7.3
    Latest GMP Certificate or a Copy of the Appropriate Licence
  • Latest GMP Certificate or a Copy of the Appropriate Licence (new)
  • 1.7.4

    Release

    1.7.4.1
    API
  • API (new)
  • 1.7.4.2
    IPIs
  • IPIs (new)
  • 1.7.4.3
    Finished Product Release Control (FPRC) Tests
  • Finished Product Release Control (FPRC) Tests (new)
  • 1.7.4.4
    Finished Product Release Responsibility (FPRR) Criteria
  • Finished Product Release Responsibility (FPRR) Criteria (new)
  • 1.7.5
    Confirmation of Contract
  • Confirmation of Contract (new)
  • 1.7.7
    SAPC Registration
  • SAPC Registration (new)
  • 1.7.8
    Registration with Registrar of Companies
  • Registration with Registrar of Companies (new)
  • 1.7.9
    Other Documents Relating to the Applicant/PHCR
  • Other Documents Relating to the Applicant/PHCR (new)
  • 1.7.11
    Manufacturing Permits
  • Manufacturing Permits (new)
  • 1.7.12
    Inspection Flow Diagram
  • Inspection Flow Diagram (new)
  • 1.7.13
    Organogram
  • Organogram (new)
  • 1.7.14
    PQR
  • PQR (new)
  • 1.7.A
    Additional GMP Documents
  • Additional GMP Documents [DESCRIPTION] (new)
  • 1.8

    Information Relating to Pharmacovigilance

    1.8.1
    Pharmacovigilance Systems
  • Pharmacovigilance Systems (new)
  • 1.8.2
    Risk Management Plan
  • Risk Management Plan (new)
  • 1.9

    Individual Patient Data - Statement of Availability

  • Individual Patient Data - Statement of Availability (new)
  • 1.10

    Foreign Regulatory Status

    1.10.1
    Tabulated List of Foreign Regulatory Status
  • Tabulated List of Foreign Regulatory Status (new)
  • 1.10.2
    Registration Certificate or Marketing Authorisation
  • Registration Certificate or Marketing Authorisation (new)
  • 1.10.4

    Data Set Similarities

    1.10.4.1
    Data Set Similarities
  • Data Set Similarities (new)
  • 1.10.4.2
    Declaration of Sameness
  • Declaration of Sameness (new)
  • 1.10.5
    RRA Reports
  • RRA Reports (new)
  • 1.10.6
    CPP (WHO certification scheme)
  • CPP (WHO certification scheme) (new)
  • 1.12

    Paediatric Development Programme

  • Paediatric Development Programme [DESCRIPTION] (new)
  • 1.A

    Additional Data

  • Additional Data [DESCRIPTION] (new)